MammaPrint: Phase III data

Agendia N.V., Amsterdam, the Netherlands
Product: MammaPrint
Business: Diagnostic
Molecular target: Not applicable
Description: Breast cancer prognostic test using a 70-gene signature chip
Indication:

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE